Page last updated: 2024-10-25

cilostazol and Asymptomatic Conditions

cilostazol has been researched along with Asymptomatic Conditions in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The coexistence of Alzheimer's disease (AD) and cerebrovascular disease pathology increases age-dependently."2.84Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction. ( Abe, K; Fukui, Y; Hishikawa, N; Ohta, Y; Sato, K; Yamashita, T, 2017)
"In the peripheral arteries, a thrombus superimposed on atherosclerosis contributes to the progression of peripheral artery disease (PAD), producing intermittent claudication (IC), ischemic necrosis, and, potentially, loss of the limb."2.50Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. ( Cafaro, G; de Gaetano, G; Di Minno, A; Di Minno, G; Lupoli, R; Petitto, M; Spadarella, G; Tremoli, E, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Minno, G1
Spadarella, G1
Cafaro, G1
Petitto, M1
Lupoli, R1
Di Minno, A1
de Gaetano, G1
Tremoli, E1
Hishikawa, N1
Fukui, Y1
Sato, K1
Ohta, Y1
Yamashita, T1
Abe, K1

Reviews

1 review available for cilostazol and Asymptomatic Conditions

ArticleYear
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
    Annals of medicine, 2014, Volume: 46, Issue:7

    Topics: Adenosine; Aspirin; Asymptomatic Diseases; Cilostazol; Clopidogrel; Fibrinolytic Agents; Humans; Int

2014

Trials

1 trial available for cilostazol and Asymptomatic Conditions

ArticleYear
Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction.
    Geriatrics & gerontology international, 2017, Volume: 17, Issue:10

    Topics: Aged; Alzheimer Disease; Asymptomatic Diseases; Brain; Cholinesterase Inhibitors; Cilostazol; Cognit

2017